151 related articles for article (PubMed ID: 36053452)
1. Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation.
Shidoh S; Savjani RR; Cho NS; Ullman HE; Hagiwara A; Raymond C; Lai A; Nghiemphu PL; Liau LM; Pope WB; Cloughesy TF; Kaprealian TB; Salamon N; Ellingson BM
J Neurooncol; 2022 Oct; 160(1):115-125. PubMed ID: 36053452
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
3. Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide.
Faustino AC; Viani GA; Hamamura AC
Clinics (Sao Paulo); 2020; 75():e1553. PubMed ID: 32935821
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme.
Reddy K; Gaspar LE; Kavanagh BD; Chen C
J Med Imaging Radiat Oncol; 2014 Dec; 58(6):714-21. PubMed ID: 24975917
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience.
Zhong L; Chen L; Lv S; Li Q; Chen G; Luo W; Zhou P; Li G
Radiat Oncol; 2019 Jun; 14(1):104. PubMed ID: 31196126
[TBL] [Abstract][Full Text] [Related]
6. Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.
Song A; Bar-Ad V; Martinez N; Glass J; Andrews DW; Judy K; Evans JJ; Farrell CJ; Werner-Wasik M; Chervoneva I; Ly M; Palmer JD; Liu H; Shi W
J Neurooncol; 2020 May; 147(3):653-661. PubMed ID: 32206976
[TBL] [Abstract][Full Text] [Related]
7. Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.
Tsien CI; Brown D; Normolle D; Schipper M; Piert M; Junck L; Heth J; Gomez-Hassan D; Ten Haken RK; Chenevert T; Cao Y; Lawrence T
Clin Cancer Res; 2012 Jan; 18(1):273-9. PubMed ID: 22065084
[TBL] [Abstract][Full Text] [Related]
8. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
Gainer JL; Sheehan JP; Larner JM; Jones DR
J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
[TBL] [Abstract][Full Text] [Related]
10. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH
Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
[TBL] [Abstract][Full Text] [Related]
12. Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.
Umphlett M; Shea S; Tome-Garcia J; Zhang Y; Hormigo A; Fowkes M; Tsankova NM; Yong RL
BMC Cancer; 2020 Jan; 20(1):47. PubMed ID: 31959133
[TBL] [Abstract][Full Text] [Related]
13. Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
Ellsworth S; Ye X; Grossman SA
Am J Clin Oncol; 2017 Jun; 40(3):219-222. PubMed ID: 26491903
[TBL] [Abstract][Full Text] [Related]
14. Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.
Berger K; Turowski B; Felsberg J; Malzkorn B; Reifenberger G; Steiger HJ; Budach W; Haussmann J; Knipps J; Rapp M; Hänggi D; Sabel M; Mijderwijk HJ; Kamp MA
J Cancer Res Clin Oncol; 2021 Jan; 147(1):253-262. PubMed ID: 32748120
[TBL] [Abstract][Full Text] [Related]
15. Multicentric non-enhancing lesions in glioblastoma: A retrospective study.
Benouaich-Amiel A; Khasminsky V; Gal O; Weiss T; Fichman S; Kanner AA; Berkowitz S; Laviv Y; Mandel J; Dudnik E; Siegal T; Yust-Katz S
J Clin Neurosci; 2021 Mar; 85():20-26. PubMed ID: 33581785
[TBL] [Abstract][Full Text] [Related]
16. Final Results of the Prospective Biomarker Trial PETra: [
Seidlitz A; Beuthien-Baumann B; Löck S; Jentsch C; Platzek I; Zöphel K; Linge A; Kotzerke J; Petr J; van den Hoff J; Steinbach J; Krex D; Schmitz-Schackert G; Falk M; Baumann M; Krause M
Clin Cancer Res; 2021 Mar; 27(5):1351-1360. PubMed ID: 33376095
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
[TBL] [Abstract][Full Text] [Related]
18. High-dose Neural Stem Cell Radiation May Not Improve Survival in Glioblastoma.
Achari R; Arunsingh M; Badgami RK; Saha A; Chatterjee S; Shrimali RK; Mallick I; Arun B
Clin Oncol (R Coll Radiol); 2017 Jun; 29(6):335-343. PubMed ID: 28188088
[TBL] [Abstract][Full Text] [Related]
19. Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns.
Comas S; Luguera E; Molero J; Balaña C; Estival A; Castañer S; Carrato C; Hostalot C; Teixidor P; Villà S
Clin Transl Oncol; 2021 Mar; 23(3):554-564. PubMed ID: 32728970
[TBL] [Abstract][Full Text] [Related]
20. Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.
Kim MM; Speers C; Li P; Schipper M; Junck L; Leung D; Orringer D; Heth J; Umemura Y; Spratt DE; Wahl DR; Cao Y; Lawrence TS; Tsien CI
J Neurooncol; 2019 Jun; 143(2):313-319. PubMed ID: 30977058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
